Malignant hyperthermia related DNA analysis (RYR1 gene) in Belgian families

Keywords:

malignant hyperthermia ; RYR1 ; sequence variant ; phenotypet ; genotype


Published online: Sep 06 2023

https://doi.org/10.56126/70.4.7

L. Heytens (*,**,***), M. Dos Santos Silva (**), J. De Puydt (*,**), K. Heytens (**), W. De Ridder (***,****,*****), J. Baets (***,****,*****), G. Mortier (******,*******)

(*) Department of Anesthesia, University Hospital Antwerp, Antwerp, Belgium.
(**) MH Research Unit, University of Antwerp, Antwerp, Belgium.
(***) Laboratory of Neurogenetics and Biobank, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
(****) Laboratory of Ultrastructural Neuropathology and Biobank, Institute Born-Bunge (IBB), University of Antwerp, Antwerp, Belgium.
(*****) Department of Neurology, Antwerp University Hospital, Antwerp, Belgium
(******) Department of Medical Genetics, University of Antwerp, Antwerp, Belgium
(*******) Department of Medical Genetics, Antwerp University Hospital, Antwerp, Belgium

Abstract

This retrospective study summarizes the results of DNA testing (Ryanodine receptor 1 (RYR1) gene sequencing) in a cohort of 34 Belgian families with proven Malignant Hyperthermia susceptibility. Eighteen different RYR1 sequence variants were found in 25 families. The most prevalent variant was p.Gly341Arg, detected in 7 families. Ten of the 18 variants are con- sidered to be pathogenic, the remainder being ‘variants of uncertain significance’. Complete phenotype and genotype concordance was obtained in 15 families ; in 7 discordance was found ; in 3 insufficient data did not allow to conclude. Discordance could be attributed to either limits in specificity of the in vitro contracture test, wrong blood sampling, or the possibility of more than one RYR1 variant in a particular family.

Even though this study reflects the known important diverseness of RYR1 variants, genetic testing can secure a diagnosis of Malignant Hyperthermia susceptibility in almost 50% of the Belgian families with known Malignant Hyperthermia.

ActaAnaestBelg-73-4-cover

About this issue

Volume 70, issue 4.

Sep 2019.

Sponsors

BeSARPP

Open access journal

This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.